Skip to content

YC Therapeutics

45 companies · 39 active · 33% AI · most in S22 (7)

Companies tagged Therapeutics

45 of 45 companies

CompanyProgram
RonanRx Inc.Full Stack Pharmaceutical Company for Personalized Peptides and GLP-1sActiveAIYCS26
FinalDoseProgrammable DNA drug destroying all cancers, unlocking 80% of targetsActiveAIYCX26
Exin TherapeuticsAI drug discovery platform for neurotherapeuticsActiveAIYCW25
Evolvere BioSciencesMaking Next-Generation Antibiotics that Outpace Bacterial EvolutionActiveAIYCS24
Kopra BioGenetically engineered viruses that teach your immune system to kill…ActiveOtherYCS24
Eris BiotechOur drugs engage the immune system to fight tumorsActiveOtherYCW24
Granza BioBuilding programmable therapeutics for the immune systemActiveOtherYCW24
ParcelBioElevated mRNA for transformative medicines.ActiveOtherYCW24
SynsoryBio"If-then" conditional logic for protein drugsActiveOtherYCW24
Velorum TherapeuticsBreakthrough medicines unlocking the biology of hemeActiveOtherYCW24
NanograbDeliver genes to any cell with AIActiveAIYCS23
Adventris PharmaceuticalsAdventris makes cancer vaccinesActiveOtherYCW23
Persist AIDeveloping long-lasting drug formulations 50% fasterActiveAIYCW23
Cisterna BiologicsHigh quality mRNA for therapeutic applicationActiveOtherYCS22
Eugit TherapeuticsEnabling Tissue Targeting of TherapiesActiveOtherYCS22
Guardian BioDendritic cell-based platform for cancer therapyActiveOtherYCS22
KemNetKemNet supplies reformulated drugs for specific groups of patients.ActiveOtherYCS22
KeylikaRedefining the Standard of Care for Iron Deficiency AnemiaActiveAIYCS22
Relevium MedicalPlatform injectable gel based therapeutic for osteoarthritisActiveOtherYCS22
Serinus BiosciencesCombinations therapy by rational designActiveAIYCS22
AlixiaTargeting the Tumor Ecosystem to address cancer drug resistance.ActiveOtherYCW22
Andson BiotechEmpowering Mass Spec for Biotech and BeyondActiveOtherYCW22
Engage BioPotent, durable, and redosable non-viral genetic medicinesAcquiredOtherYCW22
Origami Therapeutics, Inc.Oral drugs to halt neurodegenerationActiveOtherYCW22
Catena BiosciencesUsing protein coupling to build new therapiesActiveOtherYCS21
MatrubialsDeveloping milk-inspired therapeutics for infectious diseasesActiveAIYCS21
Promakhos TherapeuticsA therapeutics platform for curing inflammatory disordersActiveOtherYCS21
SafeBeatGuiding cardiac therapeutics - all from your phoneActiveAIYCS21
Sensible BiotechnologiesUnlocking the next generation of mRNA medicinesActiveOtherYCS21
Yemaachi BiotechnologyDiversifying precision cancer diagnostics and treatmentsActiveOtherYCS21
Valink TherapeuticsDiscovering bispecific antibody drug-conjugates (BsADC) against cancerActiveOtherYCW21
Gilgamesh PharmaceuticalsGilgamesh Pharmaceuticals, a Clinical stage biotechnology company…ActiveOtherYCS20
Pardes BiosciencesWe break virusesPublicOtherYCS20
Abalone BioWe create activating antibodies to treat diseases others can’t.ActiveAIYCW20
Algen BiotechnologiesUsing CRISPR to find treatments for cancer and inflammationActiveAIYCW20
Altay TherapeuticsAltay develops disease-modifying therapies targeting transcription…ActiveAIYCW20
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…ActiveOtherYCW20
Felix BiotechnologyWe’re creating programmable therapiesInactiveOtherYCW20
Encepheal TherapeuticsEncepHeal develops medications to treat substance abuse, starting…InactiveOtherYCS19
Sequence BioDiscovering the true signals of disease to power life-changing drugs.ActiveOtherYCS19
Intact TherapeuticsSmart gels for local drug delivery to the gutActiveOtherYCW19
Dorian TherapeuticsNew therapeutics to rejuvenate tissue and treat age-related diseasesAcquiredOtherYCS18
Gerostate AlphaDeveloping novel therapeutics for aging and chronic diseaseInactiveOtherYCS18
MacromoltekComputational antibody designActiveAIYCW18
ShasqiTargeting Cancer with Click ChemistryActiveAIYCW15

About Therapeutics

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.